| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Avalglucosidase alfa | neoGAA; GZ-402666; Neo-rhGAA; NeoGAA | Approved | Genzyme Corp | Nexviazyme, Nexviadyme, 耐而赞 | United States | Glycogen Storage Disease Type II | Genzyme Corp | 2021-08-06 | Glycogen Storage Disease Type II | Details |